These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6968915)

  • 21. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
    Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
    Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine in the treatment of intention myoclonus.
    Van Woert MH; Magnussen I; Rosenbaum D; Chung E
    Clin Neuropharmacol; 1983 Mar; 6(1):49-54. PubMed ID: 6189599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral conversion of L-5-hydroxytryptophan to serotonin induces drinking in rats.
    Kikta DC; Threatte RM; Barney CC; Fregly MJ; Greenleaf JE
    Pharmacol Biochem Behav; 1981 Jun; 14(6):889-93. PubMed ID: 6973156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
    Li Y; Raaby KF; Sánchez C; Gulinello M
    Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of serotonergic agents on the body temperature.
    Pawlowski L
    Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response suppression in rats after bilateral microinjection of 5-hydroxytryptophan in lateral hypothalamus.
    Hingtgen JN; Shekhar A; DiMicco JA; Aprison MH
    Biol Psychiatry; 1988 Apr; 23(7):711-8. PubMed ID: 3259438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different serotonin receptor types participate in 5-hydroxytryptophan-induced gonadotropins and prolactin release in the female infantile rat.
    Lacau-Mengido IM; Libertun C; Becú-Villalobos D
    Neuroendocrinology; 1996 May; 63(5):415-21. PubMed ID: 8738578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenergic and serotonergic mechanisms in depression and their response to amitriptyline.
    Coppen A; Wood K
    Ciba Found Symp; 1979; (74):157-66. PubMed ID: 261682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-minimization analysis of escitalopram, fluoxetine, and amitriptyline in the treatment of depression.
    Salian HH; Raghav MV; Rawat VS; Divakar A
    Indian J Pharmacol; 2023; 55(5):293-298. PubMed ID: 37929407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion.
    Clemens JA; Sawyer BD; Cerimele B
    Endocrinology; 1977 Mar; 100(3):692-8. PubMed ID: 401022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine oral treatment discloses 5-HT
    López C; Gómez-Roso M; García-Pedraza JÁ; Martín ML; Morán A; García-Domingo M
    Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram.
    Pawłowski L; Melzacka M
    Psychopharmacology (Berl); 1986; 88(3):279-84. PubMed ID: 3083448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: involvement of serotonergic system.
    Zhao X; Yu C; Wang C; Zhang JF; Zhou WH; Cui WG; Ye F; Xu Y
    Neuropharmacology; 2014 Oct; 85():131-41. PubMed ID: 24835468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
    Wang QS; Ding SL; Mao HP; Cui YL; Qi XJ
    J Ethnopharmacol; 2013 Jul; 148(2):603-9. PubMed ID: 23702040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic depression of spinal monosynaptic transmission is mediated by 5-HT1B receptors.
    Honda M; Tanabe M; Ono H
    Eur J Pharmacol; 2003 Dec; 482(1-3):155-61. PubMed ID: 14660017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of serotonin-active drugs on prolactin secretion in male rats.
    Jagiełło-Wójtowicz E; Załuska W; Szponar J; Surmaczyńska B; Wójcicki M; Kleinrok Z
    Pol J Pharmacol Pharm; 1988; 40(1):73-80. PubMed ID: 2467272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables.
    Kerkhofs M; Rielaert C; de Maertelaer V; Linkowski P; Czarka M; Mendlewicz J
    Int Clin Psychopharmacol; 1990 Oct; 5(4):253-60. PubMed ID: 2081896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effects of serotonin uptake inhibitors in depression.
    Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
    J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.